Camden Capital, LLC Novo Nordisk A S Transaction History
Camden Capital, LLC
- $916 Million
- Q1 2025
A detailed history of Camden Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Camden Capital, LLC holds 3,459 shares of NVO stock, worth $243,651. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,459
Previous 3,857
10.32%
Holding current value
$243,651
Previous $331,000
27.49%
% of portfolio
0.03%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.33 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.04 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$873 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$868 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$836 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $159B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...